NCT00464568View on ClinicalTrials.gov

A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 28, 2007

Primary Completion Date

May 16, 2007

Study Completion Date

May 16, 2007

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

GSK256066

Trial Locations (1)

14050

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY